Skip to content
Open access

TFE3‐DualNet: An Interpretable Foundation Model‐Based Deep Learning Ensemble for Diagnosing TFE3‐Rearranged Renal Cell Carcinoma From Whole‐Slide Images in a Two‐Center Cohort

Aug 2026 · Cancer Medicine · Vol 15 · 0 citations · 32 references
Medicine

Abstract

TFE3‐rearranged renal cell carcinoma (TFE3‐rRCC) is a rare, aggressive subtype that predominantly affects adolescents and young adults. Its marked morphologic heterogeneity can delay recognition and downstream confirmatory testing.

Read PDF

Similar papers

Open access Aug 2026

Real‐World Validation of the Clinical Distinctiveness of IDH‐Mutant Glioblastoma in the SEER Transition Era: A Population‐Based Study Integrating Machine Learning

This study aims to provide real‐world validation of this reclassification using the specific ICD‐O‐3 code (9445/3) from the Surveillance, Epidemiology, and End Results (SEER) “Transition Era” (2018–2022) and develop a machine learning (ML)‐based prognostic model.

De-Wei Du, Amu Jike, Dongnan Yu et al. · 0 citations
Open access Aug 2026

An Interpretable MRI-Based Machine Learning Model for Preoperative Identification of the Vascular Dissemination Phenotype in Hepatocellular Carcinoma: A Dual-Center Study

The interpretable MRI-based XGBoost model showed favorable performance for identifying the vascular dissemination phenotype in HCC, with SHAP-based interpretability and exploratory transcriptomic context.

Junhan Pan, Cong Zhang, Yitian Wu et al. · 0 citations
Aug 2026

High-dimensional overfitting and noisy diagnostic labels: reconsidering the role of BRAF copy number in primary dermal melanoma.

It is proposed that BRAF amplification in these cases more likely serves as a diagnostic corrective marker for misclassified dermal metastases, rather than a true prognostic indicator for isolated PDM.

Jingyang Zhang, Hai-Wen Wang, Qin Zheng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.